Back to search
Prurigo Nodularis (PN)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis (PN) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis (PN) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
With the arrival of dupilumab as the first available targeted therapy for PN, there is an unmet need for real-world data and translational research on the worki…
The purpose of this study is to evaluate the effectiveness of lebrikizumab in treating adults with moderate-to-severe Prurigo Nodularis (PN).
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.